G-CON Manufacturing Revenue and Competitors

College Station, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • G-CON Manufacturing's estimated annual revenue is currently $17.1M per year.(i)
  • G-CON Manufacturing's estimated revenue per employee is $155,000

Employee Data

  • G-CON Manufacturing has 110 Employees.(i)
  • G-CON Manufacturing grew their employee count by -21% last year.

G-CON Manufacturing's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
Executive Director Business DevelopmentReveal Email/Phone
3
VP InnovationsReveal Email/Phone
4
SVP, General Manager G-CON PODsReveal Email/Phone
5
Director Finance And AccountingReveal Email/Phone
6
GCBS Director BD & SalesReveal Email/Phone
7
Director OperationsReveal Email/Phone
8
Director, Business DevelopmentReveal Email/Phone
9
Director MarketingReveal Email/Phone
10
Director AutomationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is G-CON Manufacturing?

G-CON Manufacturing, Inc.'s prefabricated, turnkey cleanroom systems represent a significant transition to forward thinking in pharmaceutical and biopharmaceutical processing. G-CON Manufacturing, the innovator of autonomous cleanroom PODs, turned the challenges experienced by the biopharmaceutical industry into readily deployable, flexible, mobile and scalable cleanroom solutions. PODs are ideal for multi-product sites, rigorous containment needs, and on demand scaling of production and laboratory space. Building on its first design in 2009, G-CON now has a wide array of cleanroom PODs in their product portfolio to accommodate the increased demand from the pharmaceutical, biopharmaceutical and cell therapeutic industries. Moreover, G-CON's patent portfolio continues to grow which will effectively preclude imitators from copying G-CON's initial and more recent innovations. At G-CON, we will continue to evolve and grow with the industry to provide a comprehensive cleanroom solution that truly is flexible, scalable and fast, all for a fair and known price from the time the contract is signed.

keywords:Biotechnology,Cleantech,Hardware,Hardware Peripherals,Healthcare,Pharmaceuticals,Solar Power,Wind Power

N/A

Total Funding

110

Number of Employees

$17.1M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

G-CON Manufacturing News

2022-03-30 - G-CON Acquires Cleanroom Component Manufacturer ...

G-CON Manufacturing Inc. has acquired Plasteurop, a France-based manufacturer of critical cleanroom components.

2021-10-28 - G-CON Honored with the Europe Bioprocessing Excellence Award 2021

G-CON Honored with the Europe Bioprocessing Excellence Award 2021 We are very proud and recognize this award as a sign of the continued validation of G-CON’s efforts within the industry. COLLEGE STATION, Texas (PRWEB) October 28, 2021 IMAPAC, the organizing committee of the Europe Bioprocessin ...

2021-08-12 - G-CON Appoints Jody Lynn DeStefanis as General Counsel

Jody Lynn DeStefanis, General Counsel Jody brings a wealth of knowledge and experience in several areas critical to our continued growth... COLLEGE STATION, Texas (PRWEB) August 12, 2021 G-CON Manufacturing, the market leader in off-site prefabricated, flexible cleanroom solutions, announced t ...

2021-07-20 - Summa Equity acquires G-CON Manufacturing, the leading US-based provider of POD® cleanroom solutions USA - English España - español France - Français Deutschland - Deutsch

Through its acquisition of G-CON, Summa Equity enters the rapidly growing biopharmaceutical manufacturing market, including cell and gene therapy manufacturing. STOCKHOLM, July 20, 2021 /PRNewswire/ -- Summa Equity Fund II ("Summa") has acquired a majority stake in G-CON, a leading US-based m ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$26.4M1294%N/A
#2
$31.6M1298%N/A
#3
$19.8M13217%N/A
#4
$16.7M134-1%N/A
#5
$20.3M135N/AN/A